155 related articles for article (PubMed ID: 16146073)
1. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.
Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
Kumar P; Shankaran S; Krishnan RG
J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
5. The effect of recombinant human erythropoietin in treating the anemia of prematurity.
Wang TS; Lee CC; Deng HH; Lin JT; Chang JS; Lin ST
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):121-7. PubMed ID: 7793277
[TBL] [Abstract][Full Text] [Related]
6. Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.
Yasmeen BH; Chowdhury MA; Hoque MM; Hossain MM; Jahan R; Akhtar S
Bangladesh Med Res Counc Bull; 2012 Dec; 38(3):119-23. PubMed ID: 23540189
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
Lauterbach R; Kachlik P; Pawlik D; Bajorek I
Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity.
Halpérin DS; Félix M; Wacker P; Lacourt G; Babel JF; Wyss M
Eur J Pediatr; 1992 Sep; 151(9):661-7. PubMed ID: 1396927
[TBL] [Abstract][Full Text] [Related]
10. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
Bader D; Blondheim O; Jonas R; Admoni O; Abend-Winger M; Reich D; Lanir A; Tamir A; Eldar I; Attias D
Acta Paediatr; 1996 Apr; 85(4):496-501. PubMed ID: 8740313
[TBL] [Abstract][Full Text] [Related]
11. Anaemia of prematurity. Epidemiology, management and costs.
Meyer MP
Pharmacoeconomics; 1997 Oct; 12(4):438-45. PubMed ID: 10174310
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
13. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin responsive progenitors in anaemia of prematurity.
Emmerson AJ; Westwood NB; Rackham RA; Stern CM; Pearson TC
Arch Dis Child; 1991 Jul; 66(7 Spec No):810-1. PubMed ID: 1863130
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
18. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-term erythropoietin therapy in anemic premature infants.
Reiter PD; Rosenberg AA; Valuck R; Novak K
J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis.
Shireman TI; Hilsenrath PE; Strauss RG; Widness JA; Mutnick AH
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):582-8. PubMed ID: 8193681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
